Literature DB >> 28857218

Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells.

Anna Kjerstine Rosenmai1, Lutz Ahrens2, Théo le Godec1, Johan Lundqvist1, Agneta Oskarsson1.   

Abstract

Peroxisome proliferator-activated receptor alpha (PPARα) is a molecular target for perfluoroalkyl substances (PFASs). Little is known about the cellular uptake of PFASs and how it affects the PPARα activity. We investigated the relationship between PPARα activity and cellular concentration in HepG2 cells of 14 PFASs, including perfluoroalkyl carboxylates (PFCAs), perfluoroalkyl sulfonates and perfluorooctane sulfonamide (FOSA). Cellular concentrations were determined by high-performance liquid chromatography-tandem mass spectrometry and PPARα activity was determined in transiently transfected cells by reporter gene assay. Cellular uptake of the PFASs was low (0.04-4.1%) with absolute cellular concentrations in the range 4-2500 ng mg-1 protein. Cellular concentration of PFCAs increased with perfluorocarbon chain length up to perfluorododecanoate. PPARα activity of PFCAs increased with chain length up to perfluorooctanoate. The maximum induction of PPARα activity was similar for short-chain (perfluorobutanoate and perfluoropentanoate) and long-chain PFCAs (perfluorododecanoate and perfluorotetradecanoate) (approximately twofold). However, PPARα activities were induced at lower cellular concentrations for the short-chain homologs compared to the long-chain homologs. Perfluorohexanoate, perfluoroheptanoate, perfluorooctanoate, perfluorononanoate (PFNA) and perfluorodecanoate induced PPARα activities >2.5-fold compared to controls. The concentration-response relationships were positive for all the tested compounds, except perfluorooctane sulfonate PFOS and FOSA, and were compound-specific, as demonstrated by differences in the estimated slopes. The relationships were steeper for PFCAs with chain lengths up to and including PFNA than for the other studied PFASs. To our knowledge, this is the first report establishing relationships between PPARα activity and cellular concentration of a broad range of PFASs.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  PPARα; cellular concentration; perfluoroalkane sulfonamide; perfluoroalkyl carboxylates; perfluoroalkyl sulfonates; peroxisome proliferator-activated receptor alpha

Mesh:

Substances:

Year:  2017        PMID: 28857218     DOI: 10.1002/jat.3515

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  7 in total

1.  Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-19       Impact factor: 4.219

2.  Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.

Authors:  Greylin Nielsen; Wendy J Heiger-Bernays; Jennifer J Schlezinger; Thomas F Webster
Journal:  Toxicology       Date:  2021-11-04       Impact factor: 4.221

3.  In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.

Authors:  Nicola Evans; Justin M Conley; Mary Cardon; Phillip Hartig; Elizabeth Medlock-Kakaley; L Earl Gray
Journal:  Toxicol Appl Pharmacol       Date:  2022-06-22       Impact factor: 4.460

4.  The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.

Authors:  Emily S Marques; Juliana Agudelo; Emily M Kaye; Seyed Mohamad Sadegh Modaresi; Marisa Pfohl; Jitka Bečanová; Wei Wei; Marianne Polunas; Michael Goedken; Angela L Slitt
Journal:  Toxicology       Date:  2021-08-28       Impact factor: 4.571

5.  Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes.

Authors:  Emily Marques; Marisa Pfohl; Wei Wei; Giuseppe Tarantola; Lucie Ford; Ogochukwu Amaeze; Jessica Alesio; Sangwoo Ryu; Xuelian Jia; Hao Zhu; Geoffrey D Bothun; Angela Slitt
Journal:  Toxicol Appl Pharmacol       Date:  2022-03-23       Impact factor: 4.460

6.  Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; T Hyötyläinen; T Sinioja; C Boston; H Puckett; J Oliver; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2021-07-10       Impact factor: 4.460

Review 7.  Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances.

Authors:  Alexis M Temkin; Barbara A Hocevar; David Q Andrews; Olga V Naidenko; Lisa M Kamendulis
Journal:  Int J Environ Res Public Health       Date:  2020-03-04       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.